Inovio Pharmaceuticals Inc Spikes on Coronavirus Vaccine Development


Inovio Pharmaceuticals Inc. (NASDAQ: INO) has taken the market by storm after confirming key milestones on the development of a potential coronavirus vaccine. The stock is already up by more than 300% in less than one month, even as other stocks continue to edge lower. CBD Unlimited is another stock that continues to elicit investor interest as an emerging cannabis player.

Concerns over the spread of the coronavirus have elicited investor interest on biotechnology companies working on potential treatments of the havoc causing virus. Inovio Pharmaceutical is one of the companies that appear to have made impressive strides in an attempt to come up with a treatment to prevent further spread

Coronavirus Stock in Focus

The company has already accelerated the development timeline for its experimental DNA vaccine that will target the new strain covid-19. Preclinical testing of the experimental vaccine has already commenced. The company is on course to begin a human trial in April in the U.S, according to the Chief Executive Officer Joseph Kim. Inovio has also received a $9 million grant from the Coalition for Epidemic Preparedness innovations to ramp up preclinical trials of the proposed vaccine.

CBD Unlimited Inc. (OTC: EDCX), on the other hand, is seeking to become a household name in the CBD space backed by a robust product line. Phyto Bites is one of the company’s flagship products designed to address CBD needs for animals.

Similarly, CBD Unlimited Inc. (OTC: EDCX) has developed products for humans with accurate dosage levels. The product line is made up of oil capsules, tropical and pet products. CBD Unlimited Inc’s (OTC: EDCX)  products are ideal for addressing pain as well as anxiety and inflammation.

Coronavirus Stock in Focus

CBD product revenues are on course to surpass 2019 levels as CBD Unlimited Inc. (OTC: EDCX) embarks on an aggressive marketing campaign. The company’s products are already available in 5,600 stores across the U.S with plans in place to tie up 20,000 stores before the end of the year. The long term plan is to have a presence in more than 50,000 stores.

CBD Unlimited Inc. (OTC: EDCX) is also developing its international businesses, having already inked deals to have its products available in Puerto Rico and South Africa.

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.


Stock Market Press
110 Wall St.
New York, NY 10005

Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: SOURCE: Stock Market Press